| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/16/2008 | US7465445 Methods of preventing or treating graft versus host reaction by administering an antibody or portion thereof that binds to AILIM |
| 12/16/2008 | US7465444 Methods of suppressing or treating an inflammatory bowel disease by administering an antibody or portion thereof that binds to AILIM |
| 12/16/2008 | US7465443 Acellular antibordetella vaccine |
| 12/16/2008 | US7465441 Using interleukins, immunoglobulin fusion; genetic engineering; signaling |
| 12/16/2008 | CA2253632C Compositions and methods for treating cancers and pathogen infections using antigen-presenting cells loaded with rna |
| 12/11/2008 | WO2008151182A2 Herpes simplex virus amplicon vectors derived from primary isolates |
| 12/11/2008 | WO2008151005A2 Compositions and methods for tissue repair |
| 12/11/2008 | WO2008150969A1 Electroporation of mycobacterium and overexpression of antigens in mycobacteria |
| 12/11/2008 | WO2008150929A1 Topical compositions comprising a macromolecule and methods of using same |
| 12/11/2008 | WO2008150885A1 Modulation of the th-17 cell mediated immune responses |
| 12/11/2008 | WO2008150841A1 Compositions and methods for binding lysophosphatidic acid |
| 12/11/2008 | WO2008150577A1 Vaccine for the prevention of breast cancer relapse |
| 12/11/2008 | WO2008150530A2 Cripto binding molecules |
| 12/11/2008 | WO2008150525A1 Anti-notch1 nrr antibodies and methods using same |
| 12/11/2008 | WO2008150404A1 Raccoon poxvirus expressing genes of feline antigens |
| 12/11/2008 | WO2008150182A1 Compositions and methods for treatment of anthrax |
| 12/11/2008 | WO2008150181A1 Compositions and methods for treating anthrax exposure associated conditions |
| 12/11/2008 | WO2008149980A1 Fibrosis inhibitor |
| 12/11/2008 | WO2008149668A1 Protein-containing composition |
| 12/11/2008 | WO2008149521A1 Therapeutic agent for cancer, and method for treatment of cancer |
| 12/11/2008 | WO2008149225A2 Anti-tumour vaccine comprising full-length wt1 |
| 12/11/2008 | WO2008148884A1 Compositions and methods for treating pancreatic tumors |
| 12/11/2008 | WO2008148879A2 Use of a substance to improve postoperative outcome after end-to-end reconstruction of peripheral nerves |
| 12/11/2008 | WO2008148349A1 Use of beta-arrestin 1 for modulating t cell survival and autoimmunity |
| 12/11/2008 | WO2008148306A1 A prophylactic and/or therapeutic vaccine against allergic asthma |
| 12/11/2008 | WO2008148215A1 Estrogen receptor-related receptor gamma (err gamma) in bone and cartilage formation and methods and compositions relating to same |
| 12/11/2008 | WO2008148170A1 Human metapneumovirus immunogenic peptides, compositions, and methods of use |
| 12/11/2008 | WO2008148166A1 Clostridial toxin netb |
| 12/11/2008 | WO2008148164A1 Nasal-administered vaccines using multi-screened nalt-targeting and phagocytic polypeptide transport sequences |
| 12/11/2008 | WO2008148149A1 Method of treatment or inhibition of enterovirus 71 infection |
| 12/11/2008 | WO2008127419A3 Compositions and methods to increase the effect of a neurotoxin treatment |
| 12/11/2008 | WO2008126039A3 Cell lines, compositions comprising them for the treatment of melanomas, procedures to prepare the compositions, and treatment methods |
| 12/11/2008 | WO2008122817A3 Immunogenic compositions |
| 12/11/2008 | WO2008122441A9 Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases |
| 12/11/2008 | WO2008120101A3 The ed-a antigen of fibrinogen is associated with the neovasculature of tumour metastases |
| 12/11/2008 | WO2008116219A3 Uses of monoclonal antibody 8h9 |
| 12/11/2008 | WO2008115732A3 Anti-sclerostin antibodies |
| 12/11/2008 | WO2008109852A3 Compositions and methods for the prevention and treatment of autoimmune conditions |
| 12/11/2008 | WO2008109560A3 Amelioration of cellular stress response |
| 12/11/2008 | WO2008109155A3 Compositions and methods for treatment of cervical cancer |
| 12/11/2008 | WO2008106131A3 Combination therapy for treatment of immune disorders |
| 12/11/2008 | WO2008097970A3 Canine influenza immunogenic compositions and methods of use thereof |
| 12/11/2008 | WO2008097439A3 Anti-autoimmune antibodies for treatment of pemphigus |
| 12/11/2008 | WO2008095141A3 Redirected, genetically-engineered t regulatory cells and their use in suppression of autoimmune and inflammatory disease |
| 12/11/2008 | WO2008079713A3 Methods for the treatment of lada and other adult-onset autoimmune diabetes using immunosuppressive monoclonal antibodies with reduced toxicity |
| 12/11/2008 | WO2008065384A3 Antibodies specific for the complex of interleukin-6 and the interleukin-6 receptor |
| 12/11/2008 | WO2008057457A3 Antagonists of pcsk9 |
| 12/11/2008 | WO2008054502A3 Diagnostic and therapeutic methods related to anthrax exposure |
| 12/11/2008 | WO2008052770A3 (base-)modified rna for increasing the expression of a protein |
| 12/11/2008 | WO2008051612A3 Light-mediated anti-cell proliferative compositions and methods |
| 12/11/2008 | WO2008042941A3 Humanized anti-ephb4 antibodies and their use in treatment of oncology and vasculogenesis-related disease |
| 12/11/2008 | WO2008039164A3 Immunogenic compositions comprising anthrax spore-associated proteins |
| 12/11/2008 | WO2008024919A3 Interferon antagonists, antibodies thereto, and associated methods of use |
| 12/11/2008 | WO2008021092A8 Trypanosome microsome system and uses thereof |
| 12/11/2008 | WO2008008494A3 Methods and compositions for treating mucosal inflammation |
| 12/11/2008 | WO2008008315A3 Compositions and methods for inhibiting growth of smad4-deficient cancers |
| 12/11/2008 | WO2008005556A3 Tat-048 and methods of assessing and treating cancer |
| 12/11/2008 | WO2007150008A3 Polypeptides from african swine virus as vaccines for preventive and therapeutic use |
| 12/11/2008 | WO2007146359A3 Sea lice antigen vaccines |
| 12/11/2008 | WO2007136679A3 Targeting vegf-b regulation of fatty acid transporters to modulate human diseases |
| 12/11/2008 | WO2007124090A3 Lyophilized therapeutic peptibody formulations |
| 12/11/2008 | WO2007123906A3 Recombinant antigens for diagnosis and prevention of murine typhus |
| 12/11/2008 | WO2007120603A3 Immunogenic bcr-abl peptides and methods of use thereof |
| 12/11/2008 | WO2007114878A3 Adhesin-enterotoxin chimera based immunogenic composition against entertoxigenic escherichia coli |
| 12/11/2008 | WO2007109052A3 Methods of treating lupus using cd4 antibodies |
| 12/11/2008 | WO2007103048A3 Tlr agonist (flagellin)/cd40 agonist/antigen protein and dna conjugates and use thereof for inducing synergistic enhancement in immunity |
| 12/11/2008 | WO2007100770A3 Methods of treating inflammatory and autoimmune diseases with natalizumab |
| 12/11/2008 | WO2007092471A3 Methods for inhibition of lymphangiogenesis and tumor metastasis |
| 12/11/2008 | WO2007092451A3 Zwitterionic polysaccharides for promotion of immune system maturation and health |
| 12/11/2008 | WO2007087367A3 Methods and compositions for modulating the mobilization of stem cells |
| 12/11/2008 | WO2007022425A3 Influenza recombinant subunit vaccine |
| 12/11/2008 | WO2006076519A3 Mycobacterial mutants affecting host apoptosis |
| 12/11/2008 | WO2004093825A3 Methods for obtaining colonization factors from bacterial strains |
| 12/11/2008 | WO1999027105A9 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 12/11/2008 | US20080306333 Apparatus and Method for Endoscopic Surgical Procedures |
| 12/11/2008 | US20080306247 Antibody-containing solution formulations |
| 12/11/2008 | US20080306244 Renta: an HIV immunogen and uses thereof |
| 12/11/2008 | US20080306212 Polymer conjugates of mutated neublastin |
| 12/11/2008 | US20080305996 Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same |
| 12/11/2008 | US20080305995 Royal Jelly Peptide and Composition Containing the Same |
| 12/11/2008 | US20080305988 V-Like Domain Binding Molecules |
| 12/11/2008 | US20080305985 Isosteric Transormation |
| 12/11/2008 | US20080305142 Cell Free Biosynthesis of High-Quality Nucleic Acid and Uses Thereof |
| 12/11/2008 | US20080305131 Cancer Immunotherapy with Semi-Allogeneic Cells |
| 12/11/2008 | US20080305130 Marked Bovine Viral Diarrhea Virus Vaccines |
| 12/11/2008 | US20080305129 Highly Attenuated Pox Virus Strains, Method for the Production Thereof and the Use Thereof as Paramunity Inducers or For Producing Vector Vaccines |
| 12/11/2008 | US20080305128 Treatment of prdc in pigs |
| 12/11/2008 | US20080305127 Conjugate Vaccines |
| 12/11/2008 | US20080305126 Improved quality control for conjugate vaccines; faster and more reproducible separation; does not depend on the nature of the saccharide so it is good for combination vaccines; meningoccocus |
| 12/11/2008 | US20080305125 Mutant Forms Of EtxB and CtxB And Their Use As Carriers |
| 12/11/2008 | US20080305124 Oral pertussis vaccine and method for producing pertussis vaccine |
| 12/11/2008 | US20080305123 Functional Epitopes of Streptococcus Pneumoniae PsaA Antigen and Uses Thereof |
| 12/11/2008 | US20080305122 Ii-Key/antigenic epitope hybrid peptide vaccines |
| 12/11/2008 | US20080305121 Agents for Regulating the Activity of Interferon-Producing Cells |
| 12/11/2008 | US20080305120 Immunogenic Compositions Comprising Hmgb 1 Polypeptides |
| 12/11/2008 | US20080305119 Modified Bacteriophage Vectors and Uses Thereof |
| 12/11/2008 | US20080305118 Treatment Of Type 1 Diabetes With Inhibitors Of Macrophage Migration Inhibitory Factor |
| 12/11/2008 | US20080305117 Kir-Binding Agents and Methods of Use Thereof |
| 12/11/2008 | US20080305116 Anti-Cd154 Antibodies |
| 12/11/2008 | US20080305115 Reduced-mass, long-acting dosage forms |